Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases (NCT06374888) | Convalife (Shanghai) Co., Ltd. | 2024-04-30 |
Track Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis automatically
Every clearance here is in the API, with alerts when new ones post.